References
- Birrell, M.A., E. Hardaker, S. Wong, K. McCluskie, M. Catley, J. De Alba, R. Newton, S. Haj-Yahia, K.T. Pun, C.J. Watts, R.J. Shaw, T.J. Savage and M.G. Belvisi. 2005. Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am. J. Respir. Crit. Care Med. 172:962-971. https://doi.org/10.1164/rccm.200412-1647OC
- Bouchier-Hayes, L. and S.J. Martin. 2004. CARDINAL roles in apoptosis and NFkappaB activation. Vitam. Horm. 67:133-147. https://doi.org/10.1016/S0083-6729(04)67008-7
- Caughey, G.H. 2016. Mast cell proteases as pharmacological targets. Eur. J. Pharmacol. 778:44-55. https://doi.org/10.1016/j.ejphar.2015.04.045
- DiDonato, J.A., F. Mercurio and M. Karin. 2012. NF-κB and the link between inflammation and cancer. Immunol. Rev. 246:379-400. https://doi.org/10.1111/j.1600-065X.2012.01099.x
- Edwards, M.R., K. Strong, A. Cameron, R.P. Walton, D.J. Jackson and S.L. Johnston. 2017. Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness. J. Allergy Clin. Immunol. 140:909-920. https://doi.org/10.1016/j.jaci.2017.07.025
- Furue, M. and T. Kadono. 2017. "Inflammatory skin march" in atopic dermatitis and psoriasis. Inflamm. Res. 66:833-842. https://doi.org/10.1007/s00011-017-1065-z
- Gilmore, T.D. and M.R. Garbati. 2011. Inhibition of NF-κB signaling as a strategy in disease therapy. Curr. Top. Microbiol. Immunol. 349: 245-263.
- Han, N.R., P.D. Moon, N.R. Kim, H.Y. Kim, H.J. Jeong and H.M. Kim. 2017. Schisandra chinensis and its main constituent schizandrin attenuate allergic reactions by down-regulating caspase-1 in ovalbumin-sensitized mice. Am. J. Chin. Med. 45:159-172. https://doi.org/10.1142/S0192415X17500112
- Hawiger, J. 2001. Innate immunity and inflammation: A transcriptional paradigm. Immunol. Res. 23:99-109. https://doi.org/10.1385/IR:23:2-3:099
- Kim, H.J. and S.H. Kang. 2017. Ethnobotany, phytochemistry, pharmacology of the Korean Campanulaceae: A comprehensive review. Korean J. Plant Res. 30:240-264. https://doi.org/10.7732/kjpr.2017.30.2.240
- Kim, H.Y., S.Y. Nam, S.Y. Hwang, H.M. Kim and H.J. Jeong. 2016. Atractylone, an active constituent of KMP6, attenuates allergic inflammation on allergic rhinitis in vitro and in vivo models. Mol. Immunol. 78:121-132. https://doi.org/10.1016/j.molimm.2016.09.007
- Kim, J.Y., K.W. Park, K.D. Moon, M.K. Lee, J. Choi, S.T. Yee, K.H. Shim and K.I. Seo. 2008. Induction of apoptosis in HT-29 colon cancer cells by crude saponin from Platycodi Radix. Food Chem. Toxicol. 46:3753-3758. https://doi.org/10.1016/j.fct.2008.09.067
- Kim, S. J. , M. C. Kim, J. Y. Um and S. H. Hong. 2010. The beneficial effect of vanillic acid on ulcerative colitis. Molecules 15:7208-7217. https://doi.org/10.3390/molecules15107208
- Kuida, K., J.A. Lippke and G. Ku. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1B converting enzyme. Science 267:2000-2002. https://doi.org/10.1126/science.7535475
- Lamkanfi, M., M. Kalai, X. Saelens, W. Declercq and P. Vandenabeele. 2004. Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J. Biol. Chem. 279:24785-24793. https://doi.org/10.1074/jbc.M400985200
- Lee, Y.S., S.B. Han, H.J. Ham, J.H. Park, J.S. Lee, D.Y. Hwang, Y.S. Jung, D.Y. Yoon and J.T. Hong. 2020. IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B. J. Allergy Clin. Immunol. 146:156-168. https://doi.org/10.1016/j.jaci.2019.12.905
- Li, J.W., Y. Liu, B.H. Li, Y.Y. Wang, H. Wang and C.L. Zhou. 2016. A polysaccharide purified from Radix Adenophorae promotes cell activation and pro-inflammatory cytokine production in murine RAW264.7 macrophages. Chin. J. Nat. Med. 14:370-376. https://doi.org/10.3724/SP.J.1009.2016.00370
- Lim, J.M., B. Lee, J.H. Min, E.Y. Kim, J.H. Kim, S. Hong, J.J. Kim, Y. Sohn and H.S. Jung. 2018. Effect of peiminine on DNCB-induced atopic dermatitis by inhibiting inflammatory cytokine expression in vivo and in vitro. Int. Immunopharmacol. 56:135-142. https://doi.org/10.1016/j.intimp.2018.01.025
- Martin, R.A., J.L. Ather, L.K. Lundblad, B.T. Suratt, J.E. Boyson, R.C. Budd, J.F. Alcorn, R.A. Flavell, S.C. Eisenbarth and M.E. Poynter. 2013. Interleukin-1 receptor and caspase-1 are required for the Th17 response in nitrogen dioxide-promoted allergic airway disease. Am. J. Respir. Cell Mol. Biol. 48:655-664. https://doi.org/10.1165/rcmb.2012-0423OC
- Mitchell, J.P. and R.J. Carmody. 2018. NF-κB and the transcriptional control of inflammation. Int. Rev. Cell Mol. Biol. 335:41-84. https://doi.org/10.1016/bs.ircmb.2017.07.007
- Modena, B.D., K. Dazy and A.A. White. 2016. Emerging concepts: mast cell involvement in allergic diseases. Transl. Res.174: 98-121. https://doi.org/10.1016/j.trsl.2016.02.011
- Sakamoto, T., W. Ohashi, K. Tomita , K. Hattori , N. Matsuda and Y. Hattori. 2018. Anti-inflammatory properties of cilostazol: Its interruption of DNA binding activity of NF-kappaB from the Toll-like receptor signaling pathways. Int Immunopharmacol. 62:120-131. https://doi.org/10.1016/j.intimp.2018.06.021
- Siegmund, B. , H. A. Lehr, G. Fantuzzi and C. A. Dinarello. 2001. IL-1 betaconverting enzyme (caspase-1) in intestinal inflammation. PNASU. 98:13249-13254. https://doi.org/10.1073/pnas.231473998
- Song, P., J. Xia, C. Rezeng, L. Tong and W. Tang. 2016. Traditional, complementary, and alternative medicine: Focusing on research into traditional Tibetan medicine in China. Biosci. Trends 10:163-170. https://doi.org/10.5582/bst.2016.01105
- Theoharides, T.C., I. Tsilioni and H. Ren. 2019. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders? Expert Rev. Clin. Immunol. 15:639-656. https://doi.org/10.1080/1744666X.2019.1596800